Completed NCT00455702
This summary needs review. Please check the official study record and contact the research team for details.
In Boston Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries United States
Sponsor Massachusetts General Hospital
Condition Schizophrenia Completed NCT00085891
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Birmingham Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor AstraZeneca
Condition Schizophrenia Withdrawn NCT00988728
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries
Sponsor Merck Sharp & Dohme LLC
Condition Schizophrenia Completed NCT01149655
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Downy Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 13 Years to 17 Years
Countries United States, India, Malaysia, ...
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT00101634
This study is completed. It is testing Long Acting Anti-Psychotic for schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Schizophrenia Completed NCT02970292
This study is completed in the United States, in Canada, in Bulgaria, .... It is testing pimavanserin for schizophrenia.
Multiple locations, including Phoenix Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 55 Years
Countries United States, Canada, Bulgaria, ...
Sponsor ACADIA Pharmaceuticals Inc.
Condition Schizophrenia Completed NCT00487942
This study is completed in the United States. It is testing armodafinil for Schizophrenia.
Multiple locations, including Garden Grove Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 60 Years
Countries United States
Sponsor Cephalon
Condition Schizophrenia Completed NCT00156104
This study is completed. It focuses on Schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries
Sponsor Organon and Co
Condition Schizophrenia Completed NCT00156117
This study is completed. It focuses on Schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries
Sponsor Organon and Co
Condition Schizophrenia Completed NCT00151424
This study is completed. It focuses on Schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries
Sponsor Organon and Co
Condition Schizophrenia Terminated NCT00439634
This study was terminated in the United States and in Canada. It is testing AVE1625 for schizophrenia.
Multiple locations, including Bridgewater Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States, Canada
Sponsor Sanofi
Condition Schizophrenia Completed NCT00639483
This study is completed in Argentina, in Brazil, in Germany, .... It is testing celecoxib for schizophrenia.
Multiple locations, including La Plata Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 18 Years to 50 Years
Countries Argentina, Brazil, Germany, ...
Sponsor Pfizer
Condition Schizophrenia